| 23/04/24 | 07:00:10 | 23 Apr 2024 | | Notice of Results |
| 22/04/24 | 12:14:55 | 22 Apr 2024 | | Issue of Equity and Total Voting Rights |
| 09/04/24 | 17:00:00 | 9 Apr 2024 | | Avacta Reports Data at the AACR Annual Meeting |
| 08/04/24 | 07:00:07 | 8 Apr 2024 | | AVA6000 Abstract Release by AACR |
| 28/03/24 | 16:00:35 | 28 Mar 2024 | | Investor Webinar |
| 21/03/24 | 07:00:06 | 21 Mar 2024 | | Update on AVA6000 Phase 1a Clinical Trial Progress |
| 18/03/24 | 13:26:28 | 18 Mar 2024 | | Result of General Meeting |
| 06/03/24 | 07:00:09 | 6 Mar 2024 | | Avacta Announces AVA6000 Poster at AACR |
| 05/03/24 | 07:00:10 | 5 Mar 2024 | | Result of REX Retail Offer |
| 29/02/24 | 07:00:13 | 29 Feb 2024 | | Result of Placing |
| 28/02/24 | 16:42:19 | 28 Feb 2024 | | Proposed REX Retail Offer |
| 28/02/24 | 16:41:25 | 28 Feb 2024 | | Proposed Fundraise to progress Therapeutics |
| 16/02/24 | 07:00:06 | 16 Feb 2024 | | Share Incentive Plan/Issue of Equity |
| 22/01/24 | 10:51:02 | 22 Jan 2024 | | Issue of Equity and Total Voting Rights |
| 19/01/24 | 07:00:03 | 19 Jan 2024 | | Appointment of Christina Coughlin |
| 19/12/23 | 07:00:11 | 19 Dec 2023 | | Appointment of Chief Business Officer |
| 13/12/23 | 07:00:16 | 13 Dec 2023 | | ALS-6000-101 Phase 1a Study Data |
| 04/12/23 | 07:00:04 | 4 Dec 2023 | | Shareholder update to review AVA6000 Phase 1a data |
| 27/10/23 | 07:00:10 | 27 Oct 2023 | | Block Listing Six Monthly Return |
| 23/10/23 | 13:30:00 | 23 Oct 2023 | | Issue of Equity and Total Voting Rights |
| 18/10/23 | 13:00:00 | 18 Oct 2023 | | Block Listing Application to AIM |
| 05/10/23 | 07:00:03 | 5 Oct 2023 | | Avacta to present at AACR-NCI-EORTC conference |
| 29/09/23 | 13:30:02 | 29 Sept 2023 | | Director/PDMR Shareholding |
| 28/09/23 | 07:00:09 | 28 Sept 2023 | | Interim Results for the Period Ending 30 June 2023 |
| 20/09/23 | 14:00:01 | 20 Sept 2023 | | Issue of Equity and Total Voting Rights |
| 20/09/23 | 07:01:01 | 20 Sept 2023 | | Peel Hunt Appointed as Joint Broker |
| 20/09/23 | 07:00:07 | 20 Sept 2023 | | Appointment Dr.Christina Coughlin as a consultant |
| 19/09/23 | 07:00:03 | 19 Sept 2023 | | Successful Completion of Sixth Dose Escalation |
| 06/09/23 | 07:00:06 | 6 Sept 2023 | | Notice of Results |
| 21/07/23 | 15:00:01 | 21 Jul 2023 | | Issue of Equity and Total Voting Rights |
| 28/06/23 | 11:00:01 | 28 Jun 2023 | | Result of Annual General Meeting |
| 28/06/23 | 07:00:03 | 28 Jun 2023 | | Annual General Meeting and Shareholder Event |
| 21/06/23 | 07:00:06 | 21 Jun 2023 | | Completion of Fifth Dose Escalation in AVA6000 |
| 19/06/23 | 07:01:02 | 19 Jun 2023 | | Director Appointment |
| 19/06/23 | 07:00:04 | 19 Jun 2023 | | Statement regarding market speculation |
| 08/06/23 | 07:00:05 | 8 Jun 2023 | | AGM and Shareholder Event Detailed Agenda |
| 05/06/23 | 07:00:04 | 5 Jun 2023 | | Second Milestone in AffyXell Joint Venture |
| 02/06/23 | 07:00:06 | 2 Jun 2023 | | Posting of Annual Report and Notice of AGM |
| 01/06/23 | 07:00:10 | 1 Jun 2023 | | Avacta acquires Coris Bioconcept |
| 27/04/23 | 07:00:08 | 27 Apr 2023 | | Block Listing Six Monthly Return |
| 27/04/23 | 07:00:06 | 27 Apr 2023 | | First Patient Dosed in the US in AVA6000 Phase 1 |
| 25/04/23 | 07:00:09 | 25 Apr 2023 | | Preliminary Results |
| 21/04/23 | 14:49:02 | 21 Apr 2023 | | Issue of Equity and Total Voting Rights |
| 17/04/23 | 07:00:05 | 17 Apr 2023 | | AVA3996 data poster presented at AACR |
| 06/04/23 | 07:00:04 | 6 Apr 2023 | | 1st US Clinical Investigator AVA6000 Sites Opened |
| 05/04/23 | 07:00:03 | 5 Apr 2023 | | First Patient Dosed in Fifth Cohort of AVA6000 |
| 03/04/23 | 07:00:17 | 3 Apr 2023 | | Notice of Results and Investor Presentation |
| 27/03/23 | 07:00:04 | 27 Mar 2023 | | AVA3996 data poster presentation at AACR |
| 13/03/23 | 07:00:07 | 13 Mar 2023 | | Statement re: Silicon Valley Bank |
| 23/02/23 | 07:00:07 | 23 Feb 2023 | | Avacta Therapeutics Division Science Day |
